ONC
BeiGene, Ltd.
356.00$
-0.8%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10.0% | -34.9% | -41.1% | -10.3% | 18.8% | 6.7% | 3.9% | 20.0% | 28.5% | 27.9% | 13.3% | 39.0% | 27.5% | |
| 2.8% | 3.8% | 3.4% | 2.7% | 7.1% | 4.5% | 2.9% | 2.7% | 2.6% | 14.0% | 2.7% | 4.8% | 6.0% | |
| 12.3% | 14.6% | 11.8% | 14.1% | 11.5% | 9.5% | 8.5% | 11.5% | 10.0% | 50.5% | 8.2% | 15.3% | 20.9% | |
| -7.4% | 2.7% | -20.7% | -12.2% | 13.0% | -1.7% | -7.0% | 0.4% | 7.1% | 10.9% | -12.5% | -7.0% | -0.7% | |
| 23.3% | 26.3% | 25.7% | 11.8% | 13.3% | 8.2% | 10.4% | 4.9% | 3.4% | 19.1% | 2.7% | 4.0% | 7.2% | |
| -23.8% | -9.9% | -27.9% | -11.9% | -13.4% | -8.3% | -10.9% | -5.1% | -3.5% | -2.6% | -3.0% | -5.6% | -3.7% | |
| – | – | – | – | -0.4% | -1.2% | -8.7% | 2.0% | -0.3% | 5.3% | 3.3% | -1.0% | 1.8% | |
| -9.8% | 54.7% | 21.6% | 2.5% | 1.3% | -0.4% | -3.0% | 2.7% | 68.1% | 6.5% | 4.5% | 3.7% | 19.4% | |
| -43.6% | 16.6% | -50.4% | -20.4% | 9.5% | -6.6% | -9.7% | 19.4% | 93.8% | 33.3% | 16.1% | 39.4% | 44.7% | |
| -33.3% | -61.2% | -66.7% | -22.1% | 5.5% | -1.5% | -6.5% | 15.2% | 25.1% | 8.8% | 10.6% | 34.9% | 20.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.